findmyKOL

Derek Serna, MD

Basic profile

The Ohio State University Comprehensive Cancer Center

ORCIDNone on fileNPI
RegionWaukesha, WI · MidwestSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2013Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Derek Serna is an Oncology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 15 publications with 312 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex.

312citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

N16w24131 Riverwood Dr
Waukesha, WI 531881106

Telephone

262-696-5690

Provider last certified this registry record 6 Jan 2025.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    38.9%
    Aromatase Inhibitor21.9%
    Letrozole93%Anastrozole7%
    Part D<11 patients
    Kinase inhibitor8.3%
    Calquence51%Imbruvica25%Cabometyx13%Tagrisso11%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    16.6%
    Serotonin-3 Receptor Antagonist6.4%
    Ondansetron Hcl100%
    Part D50 patients
    Corticosteroid3.2%
    Prednisone100%
    Part D<11 patients

    + 3 more classes in this area

  • Nervous system

    14.8%
    Phenothiazine8%
    Prochlorperazine Maleate100%
    Part D53 patients
    Opioid Agonist3.8%
    Oxycodone Hcl69%Morphine Sulfate Er31%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)45.2% facility · 54.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”